middle.news

How Resmed’s 10% Revenue Growth Fuels a 13% Dividend Boost

8:31am on Friday 1st of August, 2025 AEST Healthcare
Read Story

How Resmed’s 10% Revenue Growth Fuels a 13% Dividend Boost

8:31am on Friday 1st of August, 2025 AEST
Key Points
  • 10% revenue growth in FY2025 to $5.1 billion
  • 19% increase in operating profit year-over-year
  • 13% quarterly dividend increase to $0.60 per share
  • Operating cash flow of $539 million in Q4
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Resmed (ASX:RMD)
OPEN ARTICLE